Related references
Note: Only part of the references are listed.Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
Erwan Bezard et al.
MOVEMENT DISORDERS (2013)
Parkin-Knockout Mice did not Display Increased Vulnerability to Intranasal Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Aderbal S. Aguiar et al.
NEUROTOXICITY RESEARCH (2013)
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease
Adalberto A. Castro et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
THEAFLAVIN AMELIORATES BEHAVIORAL DEFICITS, BIOCHEMICAL INDICES AND MONOAMINE TRANSPORTERS EXPRESSION AGAINST SUBACUTE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-INDUCED MOUSE MODEL OF PARKINSON'S DISEASE
A. Anandhan et al.
NEUROSCIENCE (2012)
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
J. Bove et al.
NEUROSCIENCE (2012)
Intranasal Administration of Neurotoxicants in Animals: Support for the Olfactory Vector Hypothesis of Parkinson's Disease
Rui D. S. Prediger et al.
NEUROTOXICITY RESEARCH (2012)
Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease
Rui D. S. Prediger et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
An-Li Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
The role of neuroinflammation on the pathogenesis of Parkinson's disease
Young Cheul Chung et al.
BMB REPORTS (2010)
Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease
Eduardo L. G. Moreira et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson's Disease
Rui D. S. Prediger et al.
NEUROTOXICITY RESEARCH (2010)
MPTP Lesion Causes Neuroinflammation and Deficits in Object Recognition in Wistar Rats
Wen-Fu Wang et al.
BEHAVIORAL NEUROSCIENCE (2009)
Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice
Eriko Aoki et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson's disease
Agnieszka Ciesielska et al.
INFLAMMATION RESEARCH (2009)
Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions
Claire Gibrat et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke
Lauren Fletcher et al.
JOURNAL OF NEUROSURGERY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
The olfactory vector hypothesis of neurodegenerative disease: Is it viable?
Richard L. Doty
ANNALS OF NEUROLOGY (2008)
Brain metabolism dictates the polarity of astrocyte control over arterioles
Grant R. J. Gordon et al.
NATURE (2008)
Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol
Gloria E. Meredith et al.
PARKINSONISM & RELATED DISORDERS (2008)
The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease
Rui D. S. Prediger et al.
EXPERIMENTAL NEUROLOGY (2006)
Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice
Ana I. Rojo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Diagnosis and treatment of Parkinson disease: molecules to medicine
Joseph M. Savitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice
DK Choi et al.
JOURNAL OF NEUROSCIENCE (2005)
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
ML Block et al.
PROGRESS IN NEUROBIOLOGY (2005)
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
RH Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The MPTP model of Parkinson's disease
RJ Smeyne et al.
MOLECULAR BRAIN RESEARCH (2005)
Calcium transients in astrocyte endfeet cause cerebrovascular constrictions
SJ Mulligan et al.
NATURE (2004)
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety
S Przedborski et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment
E Petroske et al.
NEUROSCIENCE (2001)
MPTP susceptibility in the mouse: Behavioral, neurochemical, and histological analysis of gender and strain differences
M Sedelis et al.
BEHAVIOR GENETICS (2000)
Share Paper
